Table 2.
IC50 (μM) of ARV, LARV, and GALARV in HepG2 and Hep3B liver cancer cells.
| Cell line | IC50 (μM) of various treatment groups |
||
|---|---|---|---|
| ARV | LARV | GALARV | |
| HepG2 | 0.82 ± 0.11 | 0.76 ± 0.08 | 0.52 ± 0.05 |
| Hep3B | 0.65 ± 0.24 | 0.40 ± 0.15 | 0.38 ± 0.18 |
IC50 (μM) of ARV, LARV, and GALARV in HepG2 and Hep3B liver cancer cells.
| Cell line | IC50 (μM) of various treatment groups |
||
|---|---|---|---|
| ARV | LARV | GALARV | |
| HepG2 | 0.82 ± 0.11 | 0.76 ± 0.08 | 0.52 ± 0.05 |
| Hep3B | 0.65 ± 0.24 | 0.40 ± 0.15 | 0.38 ± 0.18 |